First off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, here are my insights: SLRX have had recent news, especially with the Flex Pharma agreement, and their expected upcoming ASCO20 Trial Poster presentation. This + the fact that it is long due for a breakout is why I AM STILL SHORT TERM BULLISH on SLRX. Two Investor observer reports have a strong buy or hold. As of May 27th, 28.40% of SLRX stock have been in the hands of institutional investors. 3 Analyst on Zacks Ranks give it a hold rating. That being said, I expect it to extremely soon go on a bullish run and pass that sweet sweet lucrative target I been hoping for. Once it does, I may transfer positions to higher growth stocks and continue feeling like Nostradamus.
